Budesonide 200 mcg (inhalation) per rotacap

Maintenance treatment and prevention of symptoms in bronchial asthma; maintenance therapy in chronic obstructive pulmonary disease (COPD) where inhaled corticosteroids are indicated.

Budesonide is an inhaled corticosteroid that reduces inflammation and swelling in the airways. This decreases airway hyperresponsiveness and mucus production, improving breathing and preventing exacerbations when used regularly.

For inhalation use only with a rotahaler/rotacap inhaler device; do not swallow the capsule. Use exactly as prescribed, usually at the same times each day. After inhalation, rinse mouth/gargle with water and spit to reduce risk of oral thrush; not meant for immediate relief of acute breathing attacks (use a reliever inhaler if prescribed).

Hoarseness/voice change,throat irritation,cough,oral thrush (candidiasis),dry mouth,headache,nausea

Schedule H: use on prescription only. Not for acute bronchospasm/status asthmaticus; keep a quick-relief bronchodilator available. Rinse mouth after use to prevent oral candidiasis. Use with caution in active/latent infections (TB, fungal/viral), immunosuppression, liver impairment; may increase risk of pneumonia in COPD. Long-term/high-dose use may cause adrenal suppression, decreased bone mineral density, cataract/glaucoma, slowed growth in children—monitor if prolonged therapy. Do not stop abruptly without medical advice.

Strong CYP3A4 inhibitors can increase systemic budesonide levels (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, ritonavir/cobicistat); other corticosteroids (additive effects); live vaccines/immunosuppressants (increased infection risk).

Store below 25°C in a cool, dry place away from moisture and direct light. Keep rotacaps in original pack until use; keep out of reach of children.

Pulmicort 200 Rotacaps,Budamate 200 Rotacaps,Budez 200 Rotacaps,Budecort 200 Inhaler (MDI),Pulmicort 200 Inhaler